Australia lays focus on targeted treatments for triple negative breast cancer

The first award under BioCurate’s new “Proof of Concept” fund has been granted to Australia's Monash B...

August 3, 2021 | Tuesday | News
Precision biotherapeutics molecules at futuristic regimens: PROTAC & Undruggable Drug Targets

APAC is home to over 60% of the world’s population and the economical benefits of having a biopharma industry in t...

August 2, 2021 | Monday | Opinion
Taiwan links pelvic inflammatory disease with ovarian cancer in Asian women

A team of researchers at the China Medical University Hospital in Taiwan has sought to determine whether pelvic inf...

July 30, 2021 | Friday | News
Australian startup develops nasal spray technology for mental health disorders

A nasal spray technology that enables the delivery of psychedelic and non-psychedelic drugs to treat mental health disor...

July 30, 2021 | Friday | News
Australia advocates cognitive behavioural therapy for perinatal care

New research from Monash University has found that a non-drug sleep program, using Cognitive Behavioural Therapy (CBT), ...

July 29, 2021 | Thursday | News
China develops novel 'bacterial gene markers' test for early detection of colon cancer

The faecal immunochemical test (FIT) is commonly used to screen for colorectal cancer but it has low sensitivity (around...

July 29, 2021 | Thursday | News
‘Hard-to-drug targets have become our prime focus’

Hummingbird Bioscience, an innovative clinical-stage biotech company with its APAC headquarter in Singapore, is focused ...

July 29, 2021 | Thursday | Opinion
Gilead Sciences launches Asia Pacific ALL4LIVER Grant 2021 with focus on hepatitis B

American biopharma firm Gilead Sciences, Inc. has announced the launch of the 2021 Gilead Asia Pacific ALL4LIVER Grant, ...

July 28, 2021 | Wednesday | News
Industry-academia partnership in South Korea for non-alcoholic steatohepatitis treatment

Deargen, an artificial intelligence (AI)-powered drug discovery and development startup, has signed an agreement with So...

July 28, 2021 | Wednesday | News
Singapore, US assess risk of vascular inflammation for diabetes patients

A team of international scientists from Nanyang Technological University, Singapore (NTU Singapore), Tan Tock Seng Hospi...

July 28, 2021 | Wednesday | News
Japan uses quantum physics to destroy cancer cells

Scientists at Japan-based Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleague...

July 27, 2021 | Tuesday | News
China uncovers neurodegeneration mechanism of Alzheimer’s

Alzheimer’s Disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of ...

July 27, 2021 | Tuesday | News
“With three FDA-approved bispecifics across liquid and solid tumours, this feels like a turning point”

In an email interaction with BioSpectrum, EpimAb’s Founder and CEO, Dr Chengbin Wu tells us more about the company...

July 23, 2021 | Friday | Opinion
Australia examines use of hemp extracts to treat anxiety, seizures

Pharmacologists at the University of Sydney in Australia have found tantalising clues as to why low-dose CBD products co...

July 23, 2021 | Friday | News
Korean firm Celltrion developing solution to treat COVID-19 patients at home

Inhalon Biopharma, Inc., a US-based clinical-stage immunotherapy company developing an inhaled "muco-trapping" anti...

July 23, 2021 | Friday | News
Novigenix wins 2021 Felix Burda award in Medicine & Science

Novigenix SA, a leading Swiss biotech that develops and commercializes Immuno-Transcriptomic precision oncology solution...

July 22, 2021 | Thursday | News
NZ lays focus on combined screening of stomach and bowel cancer

Dr Stephen Inns and his team from the University of Otago, in New Zealand (NZ) have secured almost $250,000 from the Hea...

July 22, 2021 | Thursday | News
Quest for permanent correction of underlying genetic defect continues

After years of research, the field of gene therapies is at a tipping point. Recent years have seen immense progress in t...

July 21, 2021 | Wednesday | Opinion